MENU
SEP 16, 2020 12:15 PM EDT

Session I - Assay Development & High Content Screening Case Histories

Speakers

Show Resources
You May Also Like
SEP 10, 2020 9:00 AM PDT
C.E. CREDITS
SEP 10, 2020 9:00 AM PDT
Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
SEP 03, 2020 9:00 AM PDT
C.E. CREDITS
SEP 03, 2020 9:00 AM PDT
DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
C.E. CREDITS
This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
JUN 17, 2020 1:30 PM PDT
C.E. CREDITS
JUN 17, 2020 1:30 PM PDT
Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
NOV 05, 2020 7:00 AM PST
C.E. CREDITS
NOV 05, 2020 7:00 AM PST
DATE: Date needed, 2020 TIME: Time needed Exosomes are a population of naturally occurring mobile, membrane-limited, 30 – 100 nm in diameter, extracellular vesicles containing a large...
NOV 18, 2020 8:00 AM PST
C.E. CREDITS
NOV 18, 2020 8:00 AM PST
DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
Loading Comments...
Show Resources